Drug Re-purposing Approach and Potential Therapeutic Strategies to Treat COVID-19

Author(s): Eeda Koti Reddy, Srisravanthi Battula, Shaik Anwar*, Ayyiliath M Sajith*

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 21 , Issue 6 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

The current pandemic of COVID-19 caused by SARS-Cov-2 has posed a severe threat to the whole world with its highly infectious, progressive nature with up to 10% mortality rates. The severity of the situation faced by the whole world and the lack of efficient therapeutics to treat this viral disease have led the WHO to depend on the drug-repurposing approach to tackle this major global health problem. This review aims at highlighting the various synthetic approaches employed for the synthesis of these FDA approved drugs that have been presently used for COVID-19 treatment. Additionally, a brief overview of several therapeutic strategies is also presented. This review will encourage the scientific community across the globe to come up with better and efficient synthetic protocols and also novel chemical entities along with this core with more potent activity.

Keywords: SARS-Cov-2, COVID-19, betacoronavirus, epidemiological, acute respiratory syndrome, FDA.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 6
Year: 2021
Published on: 12 November, 2020
Page: [704 - 723]
Pages: 20
DOI: 10.2174/1389557520666201113105940
Price: $65

Article Metrics

PDF: 25